Search Results 1581-1590 of 17128 for monoclonal antibody

1. Chronic lymphocytic leukemia - Diagnosis and treatment - Mayo Clinic

   Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families. Blood. 2021; doi:10.1182/blood.2020006322. Related. Associated Procedures.

2. Pneumococcal 20-valent conjugate vaccine (intramuscular route) - Mayo Clinic

   It works by causing your body to produce its own protection (antibodies) against the disease. Pneumococcal infection can cause serious problems, such as ...

3. Efficacy and Safety of ISIS-TTR Rx in Familial Amyloid Polyneuropathy - Mayo Clinic

   Known monoclonal gammopathy of undetermined significance or multiple myeloma; Other causes of sensorimotor or autonomic neuropathy (e.g., autoimmune disease) ...

4. Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma - Mayo Clinic

   Subject has received prior treatment with an immunomodulatory agent, a proteasome inhibitor and an anti-CD38 antibody-containing regimen for at least 2 ...

5. Intrathecally Administered Gene Therapy APB-102 in Rapidly Progressive ALS Patients with SOD1 Mutations - Mayo Clinic

   Titer for neutralizing antibodies (NAb) to AAV rh10 > [1:50] at Screening ... antibody (anti-HCV) or hepatitis B surface antigen (HBsAg); or who have ...

6. Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies - Mayo Clinic

   hepatitis B core antibody [anti-HBc] and absence of HBsAg) are eligible. Participants positive for hepatitis C (HCV) antibody are eligible only if polymerase ...

7. Neurosciences Clinical Trials - Medical Professionals - Mayo Clinic

   The purpose of the study is to learn more about autoimmunity and potential mother to baby transmission of pathogenic antibodies. The collected research ...

8. MDM2 Inhibitor AMG-232 and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma - Mayo Clinic

   Patients with known Positive Hepatitis B Surface Antigen (HepBsAg) (indicative of chronic Hepatitis B), positive Hepatitis total core antibody with negative ...

9. A Study of R-ICE and Lenalidomide for Treating Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Subjects with hepatitis C antibody will be eligible provided that they do not have elevated liver transaminases or other evidence of active hepatitis ...

10. A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

    ... antibody therapy is allowed regardless of the prior treatment settings. For Phase II, Arms 1 and 2, prior cetuximab or other EGFR-targeted antibody ...